image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates

Dr.Martens

February 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • DOCS
  • Price:
  • 70.5p
The bootmaker’s Q3 statement flagged progress in its efforts to turn around performance in the US. Sales for the period were up 3% at constant currency to £267m.  Wholesale revenue rose by 9%,  with gains in Europe, EMEA and Asia-Pacific, although the Americas saw a single-digit decline, which the company says was expected. D2C grew by 1%, with ecommerce sales rising by 2% and retail revenue slipping by 1%. By region, DTC saw positive sales growth in two of its three regions: Americas +4%; APAC +17% (fuelled by Japan, one of the company’s largest markets); and EMEA -5% due to a competitive promotional marketplace. DOCS is nearing the bottom of its earnings cycle in 2024-25 and margins look set to inflect upwards later this year. < ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Dr. Martens (December 2024)
Dr. Martens (December 2023)
Dr. Martens - Will have right sized US inventory by H2 (August 2023)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW